Rgenta Therapeutics is Drug Discovery in United States that focus on operator business. Founded in 2019. They cover business area such as operator, RNA-target medicine, RNA-bind moiety, account, cell type-specific target regulation, target modulation, medical practitioner, messenger RNAs, disease gene, opportunity, drug development.
2019
( 7 years old in 2026 )
Operator
-
LabCentral
700 Main Street
Cambridge, MA 02139
United States
Private
operatorRNA-target medicineRNA-bind moietyaccountcell type-specific target regulationtarget modulationmedical practitionermessenger RNAsdisease geneopportunitydrug development
* We use standard office opening hours in near Rgenta Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rgenta Therapeutics is Drug Discovery business from United States that founded in 2019 (7 years old in 2026), Rgenta Therapeutics business is focusing on Operator.
Rgenta Therapeutics headquarter office and corporate office address is located in LabCentral 700 Main Street Cambridge, MA 02139 United States.
Rgenta Therapeutics was founded in United States.
In 2026, Rgenta Therapeutics is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rgenta Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
